Literature DB >> 24240290

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.

James W Verbsky1, Talal A Chatila.   

Abstract

PURPOSE OF REVIEW: To summarize recent progress in our understanding of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders. RECENT
FINDINGS: A number of Mendelian disorders of immune dysregulation and autoimmunity have been noted to result from defects in T regulatory cell, development and function. The best characterized of these is IPEX, resulting from mutations affecting FOXP3. A number of other gene defects that affect T regulatory cell function also give rise to IPEX-related phenotypes, including loss-of-function mutations in CD25, STAT5b and ITCH. Recent progress includes the identification of gain-of-function mutations in STAT1 as a cause of an IPEX-like disease, emerging FOXP3 genotype/phenotype relationships in IPEX, and the elucidation of a role for the microbiota in the immune dysregulation associated with regulatory T cell deficiency.
SUMMARY: An expanding spectrum of genetic defects that compromise T regulatory cell function underlies human disorders of immune dysregulation and autoimmunity. Collectively, these disorders offer novel insights into pathways of peripheral tolerance and their disruption in autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24240290      PMCID: PMC4047515          DOI: 10.1097/MOP.0000000000000029

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  95 in total

1.  T(H)-17 differentiation: of mice and men.

Authors:  Arian Laurence; John J O'Shea
Journal:  Nat Immunol       Date:  2007-09       Impact factor: 25.606

2.  The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice.

Authors:  W L Perry; C M Hustad; D A Swing; T N O'Sullivan; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.

Authors:  Masahiro Ono; Hiroko Yaguchi; Naganari Ohkura; Issay Kitabayashi; Yuko Nagamura; Takashi Nomura; Yoshiki Miyachi; Toshihiko Tsukada; Shimon Sakaguchi
Journal:  Nature       Date:  2007-03-21       Impact factor: 49.962

4.  Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation.

Authors:  Solrun Vidarsdottir; Marie J E Walenkamp; Alberto M Pereira; Marcel Karperien; Jaap van Doorn; Hermine A van Duyvenvoorde; Stefan White; Martijn H Breuning; Ferdinand Roelfsema; M Femke Kruithof; Jaap van Dissel; Riny Janssen; Jan M Wit; Johannes A Romijn
Journal:  J Clin Endocrinol Metab       Date:  2006-06-20       Impact factor: 5.958

5.  Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation.

Authors:  André Ballesteros-Tato; Beatriz León; Beth A Graf; Amy Moquin; Pamela Scott Adams; Frances E Lund; Troy D Randall
Journal:  Immunity       Date:  2012-03-29       Impact factor: 31.745

6.  Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.

Authors:  Vivian Hwa; Brian Little; Pelin Adiyaman; Eric M Kofoed; Katherine L Pratt; Gonul Ocal; Merih Berberoglu; Ron G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  2005-04-12       Impact factor: 5.958

7.  Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.

Authors:  Andrew L Mellor; Phillip Chandler; Babak Baban; Anna M Hansen; Brendan Marshall; Jeanene Pihkala; Herman Waldmann; Stephen Cobbold; Elizabeth Adams; David H Munn
Journal:  Int Immunol       Date:  2004-09-06       Impact factor: 4.823

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease.

Authors:  Bin Li; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Patrick Brennan; Talal A Chatila; Giovanna Roncador; Alison H Banham; James L Riley; Qiang Wang; Yuan Shen; Sandra J Saouaf; Mark I Greene
Journal:  Int Immunol       Date:  2007-06-22       Impact factor: 4.823

10.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561

View more
  55 in total

Review 1.  Negative Regulation of Type 2 Immunity.

Authors:  Dimitri A de Kouchkovsky; Sourav Ghosh; Carla V Rothlin
Journal:  Trends Immunol       Date:  2017-01-09       Impact factor: 16.687

2.  Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.

Authors:  Ayca Kiykim; Ismail Ogulur; Esra Dursun; Louis Marie Charbonnier; Ercan Nain; Sukru Cekic; Dilek Dogruel; Neslihan Edeer Karaca; Mujde Tuba Cogurlu; Ozlem Arman Bilir; Murat Cansever; Hasan Kapakli; Dilek Baser; Nurhan Kasap; Seyhan Kutlug; Derya Ufuk Altintas; Ahmad Al-Shaibi; Nourhen Agrebi; Manolya Kara; Ayla Guven; Ayper Somer; Cigdem Aydogmus; Nuray Aktay Ayaz; Ayse Metin; Metin Aydogan; Aysen Uncuoglu; Turkan Patiroglu; Alisan Yildiran; Sukru Nail Guner; Sevgi Keles; Ismail Reisli; Guzide Aksu; Necil Kutukculer; Sara S Kilic; Mustafa Yilmaz; Elif Karakoc-Aydiner; Bernice Lo; Ahmet Ozen; Talal A Chatila; Safa Baris
Journal:  J Allergy Clin Immunol Pract       Date:  2019-06-22

Review 3.  Newcomers in paediatric GI pathology: childhood enteropathies including very early onset monogenic IBD.

Authors:  Arzu Ensari; Judith Kelsen; Pierre Russo
Journal:  Virchows Arch       Date:  2017-07-17       Impact factor: 4.064

4.  Multisystem autoimmune disease caused by increased STAT3 phosphorylation and dysregulated gene expression.

Authors:  Francesca Todaro; Nicola Tamassia; Marinella Pinelli; Daniele Moratto; Laura Dotta; Alessia Grassi; Filippo Consonni; Mauro Giacomelli; Paolo Lionetti; Elisa Gardiman; Marco A Cassatella; Eleonora Gambineri; Roberto Berni Canani; Raffaele Badolato
Journal:  Haematologica       Date:  2019-05-09       Impact factor: 9.941

5.  Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound.

Authors:  Raymond J Louie; Queenie K-G Tan; Jennifer B Gilner; R Curtis Rogers; Noelle Younge; Stephanie B Wechsler; Marie T McDonald; Barbara Gordon; Christopher A Saski; Julie R Jones; Shelley J Chapman; Roger E Stevenson; John W Sleasman; Michael J Friez
Journal:  Am J Med Genet A       Date:  2017-03-20       Impact factor: 2.802

Review 6.  T Regulatory Cell Biology in Health and Disease.

Authors:  Fayhan J Alroqi; Talal A Chatila
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

7.  Long-term follow-up of STAT5B deficiency in three argentinian patients: clinical and immunological features.

Authors:  Liliana Bezrodnik; Daniela Di Giovanni; María Soledad Caldirola; María Esnaola Azcoiti; Troy Torgerson; María Isabel Gaillard
Journal:  J Clin Immunol       Date:  2015-03-11       Impact factor: 8.317

Review 8.  Genetics of allergy and allergic sensitization: common variants, rare mutations.

Authors:  Klaus Bønnelykke; Rachel Sparks; Johannes Waage; Joshua D Milner
Journal:  Curr Opin Immunol       Date:  2015-09-18       Impact factor: 7.486

Review 9.  The Ying and Yang of STAT3 in Human Disease.

Authors:  Tiphanie P Vogel; Joshua D Milner; Megan A Cooper
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

10.  Regulatory T Cell Induction and Retention in the Lungs Drives Suppression of Detrimental Type 2 Th Cells During Pulmonary Cryptococcal Infection.

Authors:  Darin L Wiesner; Kyle D Smith; Dmitri I Kotov; Judith N Nielsen; Paul R Bohjanen; Kirsten Nielsen
Journal:  J Immunol       Date:  2015-11-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.